ADDEX THERAPEUTICS LTD (ADXN) Stock Cash Flow
NASDAQ:ADXN - Nasdaq - US00654J2069 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 8.67M | 7.06M | -10.56M | -20.80M | -15.35M | |||
| Depreciation Amortization | 191.80K | 260.10K | 306.00K | 323.10K | 347.60K | |||
| Change In Working Capital | -1.50M | -1.23M | 213.80K | 157.70K | -761.60K | |||
| Interest Paid | 3.50K | 9.20K | 21.60K | 48.90K | 63.00K | |||
| Other non cash items | -10.83M | -11.46M | 2.04M | 3.89M | 1.06M | |||
| OPERATING CASH FLOW | -3.47M | -5.37M | -7.99M | -16.44M | -14.71M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -1.30K | -6.80K | -600.00 | -31.60K | |||
| Other Investing Activity | N/A | 4.65M | 0.00 | 3.60K | 1.20K | |||
| INVESTING CASH FLOW | N/A | 4.65M | -6.80K | 3.00K | -30.30K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -8.80K | -73.70K | -281.80K | -288.10K | -309.60K | |||
| Stock Issued/Repurchased | -158.00K | -24.00K | 4.49M | 3.99M | 19.04M | |||
| Other Financing Activity | 205.10K | 202.60K | 1.06M | -599.20K | -2.33M | |||
| FINANCING CASH FLOW | 38.30K | 104.90K | 5.26M | 3.10M | 16.40M | |||
| Exchange Rate Effect | -13.80K | 99.70K | -357.00K | -196.20K | 122.50K | |||
| CHANGE IN CASH | 1.20M | -523.70K | -3.09M | -13.53M | 1.79M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -3.47M | -5.37M | -7.99M | -16.44M | -14.71M | |||
| Capital Expenditure | N/A | -1.30K | -6.80K | -600.00 | -31.60K | |||
| FREE CASH FLOW | -3.47M | -5.37M | -8.00M | -16.44M | -14.74M | |||
All data in CHF